Frédérique Berger

Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer

Armelle Corpet, Leanne de Koning, Joern Toedling et al. · The EMBO Journal · 2010 · 186 citations · Full text

Medicine, Cancer Biology, Oncology +13

Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer

François‐Clément Bidard, William Jacot, Nicolas Kiavué et al. · JAMA Oncology · 2020 · 178 citations · Full text

Medicine, Oncology, Chemotherapy +16

The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma

Rocío Montes de, Zachary A. Gurard‐Levin, Frédérique Berger et al. · Molecular Oncology · 2014 · 90 citations · Full text

Medicine, Cancer Biology, Oncology +12

Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer

Pierre Loap, Delphine Loirat, Frédérique Berger et al. · JAMA Oncology · 2022 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer

Amanda Bortolini Silveira, François‐Clément Bidard, Marie‐Laure Tanguy et al. · npj Breast Cancer · 2021 · 74 citations · Full text

Medicine, Molecular Medicine, Oncology +17